Diagnostic Significance of the Level of Soluble Stimulating Growth Factor in Patients with Spondyloarthritis as an Early Marker of Cardiovascular Pathology | Dorogoykina | The Russian Archives of Internal Medicine

The Russian Archives of Internal Medicine
Arhivʺ vnutrennej mediciny

ISSN 2226-6704 (Print)
ISSN 2411-6564 (Online)

eng | рус

Preview

The Russian Archives of Internal Medicine

Advanced search

Archives

Download this PDF file

For citations:

Dorogoykina K.D., Safarova K.N., Fedotov E.A., Rebrov A.P. Diagnostic Significance of the Level of Soluble Stimulating Growth Factor in Patients with Spondyloarthritis as an Early Marker of Cardiovascular Pathology. The Russian Archives of Internal Medicine. 2022;12(3):221-227. https://doi.org/10.20514/2226-6704-2022-12-3-221-227

Views PDF (Rus): 228
Views PDF (Eng): 103

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2226-6704 (Print)
ISSN 2411-6564 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Editor-in-Chief

Lyudmila Yu. Ilchenko

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

K. D. Dorogoykina
Saratov State Medical University named after V.I. Razumovsky, Ministry of Health of Russian Federation
Russian Federation

Ksenia D. Dorogoykina
Department of the Internal Medicine

Saratov

K. N. Safarova
Saratov State Medical University named after V.I. Razumovsky, Ministry of Health of Russian Federation
Russian Federation

Department of the Internal Medicine

Saratov

E. A. Fedotov
Saratov Regional Blood Center
Russian Federation

Saratov

A. P. Rebrov
Saratov State Medical University named after V.I. Razumovsky, Ministry of Health of Russian Federation
Russian Federation

Department of the Internal Medicine

Saratov

Notifications